EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets

Melika AmeliMojarad, Mandana AmeliMojarad

CNS Neuroscience & Therapeutics · 2024-07 · 30 (7)

DOI: 10.1111/cns.14856 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 19.07.2024. Verfasst von Melika AmeliMojarad und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioprocess Engineering, Institute of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechn…. Hauptthemen laut MEDLINE: Alzheimer Disease, Microglia, Neuroinflammatory Diseases. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Alzheimer's disease (AD), the main cause of dementia, is characterized by synaptic loss and neurodegeneration. Amyloid‐β (Aβ) accumulation, hyperphosphorylation of tau protein, and neurofibrillary tangles (NFTs) in the brain are considered to be the initiating factors of AD. However, this hypothesis falls short of explaining many aspects of AD pathogenesis. Recently, there has been mounting evidence that neuroinflammation plays a key role in the pathophysiology of AD and causes neurodegeneration by over‐activating microglia and releasing inflammatory mediators.

Methods

PubMed, Web of Science, EMBASE, and MEDLINE were used for searching and summarizing all the recent publications related to inflammation and its association with Alzheimer's disease.

Results

Our review shows how inflammatory dysregulation influences AD pathology as well as the roles of microglia in neuroinflammation, the possible microglia‐associated therapeutic targets, top neuroinflammatory biomarkers, and anti‐inflammatory drugs that combat inflammation.

Conclusion

In conclusion, microglial inflammatory reactions are important factors in AD pathogenesis and need to be discussed in more detail for promising therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMicrogliaNeuroinflammatory DiseasesHumansAnimalsAnti-Inflammatory AgentsInflammation

Stichwörter der Autor:innen

Alzheimer's diseaseNSAIDsmicroglianeuroinflammation

Substanzen

Anti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Bioprocess Engineering, Institute of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.

Zitieren

APA

AmeliMojarad, M., & AmeliMojarad, M. (2024). The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets. CNS Neuroscience & Therapeutics, 30(7). https://doi.org/10.1111/cns.14856

Vancouver

AmeliMojarad M, AmeliMojarad M. The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets. CNS Neuroscience & Therapeutics. 2024;30(7). doi:10.1111/cns.14856

BibTeX
@article{AmeliMojarad2024,
  author = {AmeliMojarad, Melika and AmeliMojarad, Mandana},
  title = {The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  volume = {30},
  number = {7},
  doi = {10.1111/cns.14856}
}
Kostenlos starten →